InvestorBrandNetwork (IBN) Content Platform

Shimmick (NASDAQ: SHIM), a leading water infrastructure company, recently announced the pricing of its initial public offering of 3,575,000 shares of its common stock at a price to the public of $7 per share. Shimmick also granted the underwriters a 30-day option to purchase up to an additional 536,250 shares at the initial public offering price, less underwriting discounts and commissions. The shares have commenced trading on the Nasdaq Global Market under the ticker symbol SHIM. Shimmick intends to use the net proceeds to repay outstanding indebtedness, with any remaining amounts to be used for working capital and other general corporate purposes, including the potential funding of future opportunistic acquisitions. Roth Capital Partners is acting as sole book-running manager and Craig-Hallum Capital Group LLC is acting as co-manager for the offering.

To view the full press release, visit https://ibn.fm/0IOv8

About Shimmick

Shimmick is a leading provider of water infrastructure solutions nationwide. Shimmick has a long history of working on complex water projects, ranging from the world’s largest wastewater recycling and purification system in California to the iconic Hoover Dam. Shimmick is led by industry veterans, many with over 20 years of experience, and works closely with its customers to deliver complete solutions, including long-term operations and maintenance.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DealFlow Events, host of hundreds of conferences over the past two decades, has announced its next event: the Microcap Conference. Scheduled for Jan. 30–Feb. 1, 2024, in Atlantic City, New Jersey, the Microcap Conference will feature a multitrack format that includes microcap company presentations, mainstage keynote presentations and panel discussions. According to the announcement, some 60 companies will be presenting during the two-day event, which will be attended by more than 500 institutional and accredited investors, including senior executives, institutional and high net-worth investors, representatives from brokerage firms and hedge funds, equity research analysts and more. The event offers an ideal setting for CEOs to present company overviews to professional investors in both group and one-on-one formats. Presenting companies come from a diverse array of sectors, including financial services, industrial assets, cybersecurity, healthcare, pharmaceuticals, biotechnology, clean energy, media and entertainment. The event agenda features a launch party with casino games, drinks and music as well as the Wild Wild West Afterparty, that includes an open bar, hors d’oeuvres, handrolled cigars, real-money games and live music.

To learn more about the conference, visit https://ibn.fm/I7I43

To view the full press release, visit https://ibn.fm/y2wh6

About DealFlow Events

DealFlow Events, the host of hundreds of conferences over the past 20 years, presents the Microcap Conference. DealFlow Events is renowned for its SPAC, PIPE, Reg A, Activist Investor, Venture Debt and other investment-themed conferences. To learn more about the company, please visit www.DealFlowEvents.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a proprietary SaaS technology company delivering mobile live dealer technology to online gaming operators globally, is reporting on its financial results for Q3 2023, the three-month and nine-month periods ended Sept. 30, 2023. Highlights of the report include increased growth in player activity, which is viewed as a strong indicator for future revenue growth, and revenues of $436,926 (three month) and $1,138,323 (nine month) from the Live Dealer platform, which is a 38% year-over-year increase for the three-month period and a 69% year-over-year increase for the nine-month period. Operational highlights include several key performance indicators (“KPIs”), including wagering turnover for the three-month period coming in at $446 million compared to $396 million the previous quarter; the number of wagers placed, or betspots, totaling 9.3 million compared to the 10.2 million during the previous quarter; and average daily wagering turnover reported at $4.88 million compared to the previous quarter of $4.4 million, an 11% increase quarter over quarter.

In addition, the company reported that it plans a nonbrokered private placement of unsecured convertible debentures, projected to result in gross proceeds of up to C$5 million. According to the report, the Debentures are expected to mature on May 3, 2025, following closing of the offering, with each $1,000 debenture bearing simple interest at 10% per annum, calculated and paid quarterly. “We continue to see positive revenue growth in our Q3 supported by momentum in several KPI’s we track,” said Playgon Games CEO Darcy Krogh in the press release. “Management is confident we are on the right path with our current business opportunities along with our upcoming launch in Ontario and Latin America as we continue extend our reach globally.”

To view the full press release, visit https://ibn.fm/wudNS

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Playgon’s current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com.

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Siyata Mobile (NASDAQ: SYTA), a global vendor of push-to-talk over cellular (“PoC”) devices and cellular signal booster systems, today announced that it will effect a 1-for-7 reverse stock split of its common share, no par value per share (“common share”). The reverse stock split will become effective at 12:01 a.m. Eastern Time on Monday, Dec. 4, 2023, and, at the opening of the market on Dec. 4, Siyata’s common share will commence trading on the Nasdaq Capital Market on a post-split basis. The company’s common share will continue to trade on the Nasdaq Capital Market the existing trading symbol, SYTA, and a new CUSIP number 83013Q 707 has been assigned as a result of the reverse stock split. The move is primarily intended to bring the company into compliance with the $1.00 minimum bid price requirement for maintaining its listing on the Nasdaq. There is no guarantee that Siyata will meet the minimum bid price requirement.

To view the full press release, visit https://ibn.fm/5aGN4

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next generation push-to-talk (“PTT”) over cellular devices, cellular booster systems and video monitoring solutions. Its in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Its portfolio of enterprise grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signals in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. For its video monitoring system, Siyata integrates software that it licenses with off-the-shelf hardware providing customers with an integrated advanced camera system for management and visual monitoring of their fleet vehicles. Siyata’s common shares and its previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. Visit SiyataMobile.com and UnidenCellular.com to learn more.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, will be presenting at the MedInvest Oncology Investor Conference. According to the announcement, Dr. David Young, president of research and development for Processa, will be presenting virtually during the conference, which is scheduled for Dec. 5–6, 2023, in Palo Alto, California. Young’s presentation will begin at 1:35 p.m. PST on Dec. 5. In addition to Young’s virtual presentation, the company noted that Processa CEO George Ng will be attending the event in person and will be available for one-on-one meetings with investors.

To view the presentation, visit https://ibn.fm/AkCiD

To view the full press release, visit https://ibn.fm/soaGK

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing next-generation chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining optimal dosage regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but also will increase the probability of FDA approval for its next-generation chemotherapy drugs. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of these FDA-approved drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s approach to drug development is based on more than 30 years of drug-development expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. Using its proven Regulatory Science Approach, the Processa team has experience defining the optimal dosage regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s NGC drugs are expected to include fewer patients experiencing side effects that lead to dose discontinuation; more significant cancer response; and a greater number of patients, in excess of 200,000 for each NGC drug, who will benefit from each NGC drug. Currently under development are three next-generation chemotherapy oncology treatments: Next Generation Capecitabine (PCS6422 and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic and other cancers), Next Generation Gemcitabine (PCS3117 to treat pancreatic, lung, ovarian, breast and other cancers), and Next Generation Irinotecan (PCS11T to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Save Foods (NASDAQ: SVFD), an agrifood tech company that focuses on sustainable operations by significantly reducing the use of pesticides, tackling N2O emissions and producing clean-label, plant-based food, is reporting that its green-treatment solution has been chosen by Sun Pacific for use on Cuties(R) clementines; this is the third consecutive season that Sun Pacific has used Save Foods’ solution to treat its iconic Cuties product. A leading U.S.-based grower, packer and marketer, Sun Pacific is a cornerstone operation in the industry with its Cuties brand represents the forefront of large-scale California-grown clementine and mandarin production across North America. Save Foods green-treatment solution features a combination of the company’s technology and oxidizers designed to protect fresh fruit and vegetables from microbial spoilage and foodborne pathogens that cause decay and foodborne illnesses. The treatments, which can be applied at various stages throughout the production process, leave no harmful residues on the produce or in the environment.

To view the full press release, visit https://ibn.fm/fYt3z

About Save Foods Inc.

Save Foods is an innovative agrifood tech company that, through its three operational arms, delivers integrated solutions for improved safety, quality and sustainability every step of the way from field to fork. Save Foods Ltd., Save Foods’ majority-owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination, significantly reduce the use of hazardous chemicals and prolong fresh produce’s shelf life. Nitrousink Ltd., Save Foods’ majority-owned Israeli subsidiary, contributes to tackling greenhouse gas emissions, offering a pioneering solution to mitigate nitrous oxide emissions, a potent greenhouse gas with 265 times the global warming impact of carbon dioxide. Nitrousink aims to promote agricultural practices that are both environmentally friendly and economically viable. Plantify Foods, Save Foods’ minority-owned Canadian subsidiary, offers a wide range of clean-label healthy food options that are nutritious, gluten free and nonallergenic; that use whole natural ingredients; and that are easy to prepare. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BlockQuarry (OTC: BLQC), a leading Texas-based energy and infrastructure company, is providing an update on the operation of its new Missouri site. The company recently announced the appointment of Lawrence Davis as chief operating office, and the report noted the pivotal part he has played in driving the operational vision for BlockQuarry, including the successful move, reintegration and launch of BlockQuarry’s new self-mining site in Macon, Missouri, which the report called one of BlockQuarry’s most notable achievements. The report noted that currently, BlockQuarry self-mining operations are live with two pods and annual revenue projected of $1.4 million to $1.7 million. In addition, the report said the company’s expansion plans include powering up a total of four pods by the end of the year, with the Macon site designed for immediate scalability, ramping up to 9 MW of operational power from the outset. The projected annual revenue for the site with this increase in capacity would be between $3 million and $3.4 million. BlockQuarry is committed to pushing boundaries and establishing itself as an industry leader. The new site in Macon, which allows the company to showcase its expertise, represents the company’s focus on accelerating the growth of BlockQuarry and Pantheon mining operations. “I couldn’t be more proud to say with confidence that BlockQuarry has delivered on its promise, achieving operational status before year-end, thanks to our seamless transition to the new Missouri site,” said BlockQuarry president and chair Alonzo Pierce in the press release. “The fact that we were able to turn around this new site, post-Gaffney court ruling, in the short amount of time that we did, reflects our unwavering confidence in Lawrence’s leadership and the team that BlockQuarry has put together.”

To view the full press release, visit https://ibn.fm/ncffq

About BlockQuarry Corp.

BlockQuarry stands as a renowned U.S. collaborator in the fields of energy and infrastructure, with a profound commitment to championing the implementation of carbon-negative industrial energy and fostering its establishment on a widespread scale. The company’s expertise lies in provisioning green, sustainable and economically viable energy solutions that cater to industries with substantial power requirements, such as data storage hubs, manufacturing and cryptocurrency mining. Capitalizing on its extensive network in areas best suited for the development of data centers and computational infrastructure, the company is equipped to navigate its clients toward the precise energy solution that their enterprise needs. BlockQuarry shoulders the responsibility of all requisite permits and engagement processes, allowing its clientele to devote their attention fully to the administration of their businesses. For more information about the company, visit www.BlockQuarry.io.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Jushi Holdings (OTCQX: JUSHF) is a vertically integrated, multi‑state cannabis company engaged in developing and operating high-end retail locations, premium brands, and state-of-the-art cultivation, manufacturing, and processing facilities in both medical and adult‑use markets. The company is focused on building a diverse portfolio of cannabis assets through opportunistic investments, acquisitions, and pursuing application opportunities in attractive limited license markets. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. The company has targeted assets in highly populated, limited licensed medical markets with a trajectory toward adult-use legalization and limited license, fast-growing, large adult-use markets. Operating under the Jushi umbrella is the Beyond Hello, Nature’s Remedy, and NuLeaf retail brands of cannabis dispensaries. For more information, visit the company’s website at https://jushico.com.

For further information, please contact: [email protected]

To view IBN’s virtual coverage of Noble’s 19th annual small and micro-cap investor conference, visit https://ibn.fm/NobleCon19

About IBN’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating at this year’s NobleCon. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Uranium Energy (NYSE American: UEC) and TerraPower have entered a memorandum of understanding (“MOU”) with objectives of reestablishing domestic supply chains of uranium fuel. According to the announcement, the MOU will allow TerraPower and UEC to explore the potential supply of uranium for TerraPower’s first-of-kind Natrium(TM) reactor* and energy storage system. Being built in Kemmerer, Wyoming, the Natrium demonstration project will be a commercial scale plant upon completion and will begin operations within a decade. “UEC is pleased to form strategic relationships that support the emerging uranium demand from SMRs and ARs, and we look forward to working with TerraPower and the prospect of providing the uranium they need to operate their Wyoming Natrium reactor,” said Amir Adnani, UEC president and CEO. “In these geopolitically complex times, UEC’s vision is to be the leading provider of conflict-free, American uranium for the existing, as well as the new reactors that will come online.”

To view the full press release, visit https://ibn.fm/2ZSUy

About Uranium Energy Corp.

Uranium Energy is the fastest growing supplier of the fuel for the green energy transition to a low carbon future. UEC is the largest, diversified North American focused uranium company, advancing the next generation of low-cost, environmentally friendly ISR mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms in South Texas and Wyoming. These platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, the company has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of U.S. warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

*A TerraPower and GE Hitachi technology

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, has released positive phase 2 topline safety and efficacy data for CYB003, its proprietary deuterated psilocybin analog, being developed for the treatment of major depressive disorder (“MDD”). According to the announcement, study participants experienced a rapid, robust and clinically significant reduction of depression symptoms after a single dose of CYB003, with a clear incremental benefit of a second dose. The study showed a primary efficacy endpoint achieved with an impressive mean -14 point difference in Montgomery-Asberg Depression Rating Scale (“MADRS”) score reduction from baseline between CYB003 (12 mg) vs. placebo (p=0.0005) at three weeks, with incremental MADRS score reductions seen with 79% of patients in remission from depression after only two doses of CYB003 (12 mg). The company noted a favorable safety and tolerability profile with no treatment-related serious adverse events at both 12 mg and 16 mg doses.

Looking forward, the company anticipates submitting topline data to the U.S. Food and Drug Administration (“FDA”), along with a request for an end-of-phase-2 meeting. The company expects to receive additional 12-week durability data from the study in Q1 2024 and is planning to begin recruiting for a CYB003 phase 3 study by the end of Q1 2024. “We are delighted to share that CYB003 achieved the primary efficacy endpoint in this study and showed rapid and statistically significant improvements in depression symptoms after a single dose, with a clear incremental benefit of a second dose, resulting in four out of five patients in remission from their depression at six weeks,” said Cybin CEO Doug Drysdale in the press release. “This is an impressive finding and follows on from the unprecedented interim results we announced earlier this month. Importantly, the strength of the data supports progression to a phase 3 study of CYB003 for the treatment of MDD. . . . Completing our phase 2 study and presenting this extraordinary topline safety and efficacy data represents a much-anticipated milestone for us — a goal that we have all been tirelessly working toward. Our objective remains to design and deliver improved treatments for those suffering with mental health disorders, and we believe that we are one step closer to achieving that goal.”

To view the full press release, visit https://ibn.fm/RiTeo

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental-health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has launched sales of its Automated Gunshot Detection (“AGD”) systems for both indoor and outdoor settings. According to the announcement, the systems are available as standalone sensors that can be easily mounted to existing structures or with an optional pole-mounting kit and solar power for installation flexibility.

The new AGD system is completely automated and features precision localization, enabling the identification of shots in both horizontal and vertical planes (location and elevation). This ability translates into a significant reduction in police and security response times, thereby expediting the resolution of active shooter threats and helping to save lives. In addition, gunshot detection contributes to reduced false alarms, which can lead to threat fatigue and cause potential inappropriate responses in time of true danger. Gunshot detection systems also complement other security solutions to provide better protection.

Knightscope noted that its existing clients will be able to add the AGD system to any new K1 Blue Light Tower orders; clients will also have the option to upgrade their existing devices. Currently, more than 7,000 KSCP security devices are deployed across the country.

“Once AGD detects a shot, notifications are delivered in less than two seconds (assuming sufficient cellular service) using a multisensor system that is incredibly reliable and minimizes false alarms,” the company stated in the press release. “Knightscope believes that an onsite, hyperfocused, real-time system is significantly more effective than attempting a citywide approach over vast areas.”

To view the full press release, visit https://ibn.fm/D4XIA

About Knightscope, Inc.

Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is featured in a recent Proactive Investors interview. According to the announcement, Vivos Therapeutics CEO Kirk Huntsman joined Proactive host Steve Darling to discuss a “milestone” moment for the company: the 510(k) clearance from the U.S Food and Drug Administration (“FDA”) for the treatment of severe obstructive sleep apnea (“OSA”) in adults using Vivos’ removable CARE oral appliances. The FDA approval includes Vivos’s flagship DNA oral appliance along with its mRNA and mmRNA oral appliances. During the interview, Huntsman noted that Vivos is now the first company to receive FDA approval and bring to market a treatment for patients with severe OSA that is an alternative to continuous positive airway pressure (“CPAP”) therapy or surgical neurostimulation implants. “The operative and most important word there is severe sleep apnea,” said Vivos Therapeutics CEO Kirk Huntsman during the interview. “This is a clearance by the FDA for doctors who use our devices to treat severe apnea. Other oral appliances, including our own, have had clearances for the FDA for years to treat mild to moderate sleep apnea. But as every sleep specialist will tell you, in most patients, the greatest amount of damage is done when it gets to a severe state. So patients are at greater risk for all the comorbidities that go along with sleep apnea. The hypertension, the stroke, the Alzheimer’s — all the various comorbidities of sleep apnea are made worse when you get to the severe level. And it cuts life expectancy down by as much as 10 years. So to be able to treat, and to have the clearance to treat, severe sleep apnea with our oral appliance technology is absolutely a breakthrough. I would venture to say that since the advent of CPAP, there hasn’t been a more important regulatory clearance than the one we announced this morning.”

To view the full interview, visit https://ibn.fm/FdBQD

To view the full press release, visit https://ibn.fm/v39Qb

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in the treatment of approximately 40,000 patients worldwide by more than 1,850 trained dentists. The Vivos Method includes treatment regimens that employ the proprietary Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has been selected by Blue Shield of California to expand the nonprofit health plan’s services. According to the announcement, Blue Shield of California is adding Dario’s at-home solution for high blood pressure, or hypertension, that combines personalized health coaching and tech-enabled monitoring. The addition is part of Blue Shield of California’s Wellvolution program, which was created to offer personalized solutions to address individual needs; Wellvolution offers at least one Spanish language program for each health need covered under the platform, including diabetes, weight management, mental health, tobacco cessation and hypertension. Dario’s program is available in both English and Spanish, and features intelligent technologies combined with personal coaching support to help members track and reduce hypertension, while improving health behaviors. Blue Shield of California is committed to creating a healthcare system that is sustainably affordable; the organization is a tax-paying, nonprofit, independent member of the Blue Shield Association with more than 4.8 million members. “Over 30% of Californians have hypertension,” said DarioHealth chief medical officer Omar Manejwala, MD, in the press release. “By offering Dario for Hypertension through Wellvolution at no additional cost, more Californians have the chance to improve their cardiovascular health, which directly correlates to instances of heart disease and stroke, both leading causes of death in California.”

To view the full press release, visit https://ibn.fm/isTLU

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, has released a shareholder letter from CEO Georg Ng. In the letter, Ng notes that because he was recently appointed CEO, he wanted investors to get a corporate update from the “new voice.” Ng confirmed that the company’s focus on the development of next-generation chemotherapy (“NGC”) agents will not change as chemotherapy drugs remain an important and viable treatment option for cancer. Ng noted that issues and limitations are often associated with the use of chemotherapy and that Processa can address these challenges by providing patients with potentially safer and more effective chemotherapy treatments through NGCs. The letter included an overview of the three NGCs currently in development: NGC-Capecitabine (PCS6422), NGC-Gemcitabine (PCS3117) and NGC-Irinotecan (PCS11T).

He also articulated Processa’s forward-looking vision, recapped the company’s experience team and provided an overview of the company’s stable financial situation and business development opportunities. “I feel that Processa is well-positioned for success and is uniquely positioned to disrupt and expand current chemotherapy and oncology therapeutics,” said Processa Pharmaceuticals CEO George Ng in the shareholder letter. “To that end, we are looking forward to our upcoming meeting with the FDA and to potentially releasing top-line data during the second half of December. Regarding Processa’s pivot to focus on oncology drug development, change forces adaptation that can be stewarded by effective leadership. My intention as the new CEO is to promote, encourage and facilitate advancement in the areas in which we excel. With our potentially revolutionary NGC drug products, Processa is poised to be a global leader in chemotherapy and oncology, and I am incredibly honored to have the opportunity to lead Processa through this transition and work to create shareholder value.”

To view the full press release, visit https://ibn.fm/0dxLu

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing next-generation chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining optimal dosage regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but also will increase the probability of FDA approval for its next-generation chemotherapy drugs. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of these FDA-approved drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s approach to drug development is based on more than 30 years of drug-development expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. Using its proven Regulatory Science Approach, the Processa team has experience defining the optimal dosage regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s NGC drugs are expected to include fewer patients experiencing side effects that lead to dose discontinuation; more significant cancer response; and a greater number of patients, in excess of 200,000 for each NGC drug, who will benefit from each NGC drug. Currently under development are three next-generation chemotherapy oncology treatments: Next Generation Capecitabine (PCS6422 and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic and other cancers), Next Generation Gemcitabine (PCS3117 to treat pancreatic, lung, ovarian, breast and other cancers), and Next Generation Irinotecan (PCS11T to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced the launch of INM-089, a cannabinol (“CBN”) analog, to investigate its effects in the treatment of age-related macular degeneration (“AMD”). INM-089 is InMed Pharmaceuticals’ second ocular pharmaceutical program. “We are very pleased that this research has led to the identification of a lead CBN analog candidate to advance to additional in vivo studies as part of the preclinical development program,” said InMed’s scientific advisor, Dr. Mauro Maccarrone. “Early studies show promising neuroprotective effects of INM-089, leading to the preservation of the retinal function at the back of the eye. Neuroprotection in AMD remains an unmet medical need and a new treatment option may help solve this multifactorial disease.”

To view the full press release, visit https://ibn.fm/jwXIC

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, visit www.InMedPharma.com and www.BayMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, has entered a partnership with Drake State Community and Technical College. The five-year agreement will include developing customized learning platforms to meet the specific needs of the regional workforce and providing accessible, high-quality educational resources to support professional development and skills enhancement. The partnership is particularly noteworthy because Drake State is the first community college and the first higher education institution in Alabama to leverage the National Association for Equal Opportunity in Higher Education (“NAFEO”)-Amesite Alliance; the partnership allows the college to extend its educational reach beyond traditional classroom settings and work with regional businesses to address local workforce learning needs.

Officials from NAFEO noted that the alliance with Amesite is “yielding positive results,” particularly because it is critical for professionals to have certifications that enable them to advance economically in their careers. The organization is focused on engaging other NAFEO members, including 106 Historically Black Colleges and Universities (“HBCUs”) and some 70 predominantly Black institutions (“PBIs”). “NAFEO, as the nation’s only advocacy and membership organization for all HBCUs and predominantly Black institutions, has created an efficient and effective way of engaging the most economically significant cohort of institutions that impact workforce diversity in the United States,” said Amesite CEO Dr. Ann Marie Sastry in the press release. “We are proud to be part of this alliance and to work with members like Drake State. This collaboration is an important step for us in Alabama. Our goal is to extend our learning solutions to NAFEO’s members. This agreement with Drake State is an important part of our commitment to enhancing education through technology.”

To view the full press release, visit https://ibn.fm/ejWav

About Amesite Inc.

Amesite is an ed-tech, SaaS company with the most advanced artificial intelligence (“AI”)-driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multibillion-dollar online learning markets in business and education. For more information about the company, please visit www.Amesite.io.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

The Pension Benefit Guaranty Corporation (“PBGC”), a federal agency tasked with protecting the retirement security of more than 33 million Americans in single-employer and multiemployer pension plans, has renewed its PBGC Office of Benefits Administration (“OBA”) Information Systems Security Risk Management Services contract with leading managed cybersecurity and compliance provider CISO Global’s (NASDAQ: CISO) wholly owned subsidiary TalaTek. According to the update, TalaTek will continue to support the management and oversight of OBA’s compliance and security requirements and its continuous monitoring program that is used to safeguard and protect PBGC’s critical systems and data. “As a long-time PBGC partner, we look forward to continuing to help the agency protect its mission-critical operations and strengthen its data security,” said Baan Alsinawi, managing director of strategy and risk, CISO Global, and founder of TalaTek. “In today’s cyber risk environment, it is imperative that federal agencies continuously assess their enterprise environments based on a holistic approach to risk management. We will continue to deliver best-in-class solutions enabled by our team of experts.”

To view the full press release, visit https://ibn.fm/ZFgBJ

About CISO Global Inc.

CISO Global, based in Scottsdale, Arizona, is an industry leader as a managed cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CISO.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tingo Group (NASDAQ: TIO), a profitable, multinational fintech, agrifintech, food-processing and commodity-trading company, has received a request for information from the NASDAQ Stock Market. According to the announcement, a temporary suspension of trading in the TIO securities imposed by the Securities & Exchange Commission (“SEC”) on Nov. 14, 2023, was scheduled to expire at 11:59 pm EST on Nov. 28, 2023. However, NASDAQ notified Tingo Group management that the exchange will continue to keep the company’s securities halted pending review of the requested information. “The company intends to make its response to NASDAQ’s information request within the next three to four business days and will fully cooperate with NASDAQ to assist them in completing their review as quickly as possible, with the goal of achieving the resumption of trading in the company’s securities at the earliest opportunity,” the company stated in the press release.

To view the full press release, visit https://ibn.fm/WtdJS

About Tingo Group Inc.

Tingo Group is a global fintech, agrifintech, food processing and commodity trading group of companies with operations in Africa, Southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is a leading agrifintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device as a service” smartphone and a value-added service platform. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing these farmers with access to services that include, among others, the Nwassa “seed-to-sale” marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa, offering a wide range of business-to-consumer (“B2C”) and business-to-business (“B2B”) services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, groundnut oil, nut products, wheat, millet and maize; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Centre. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China along with Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore, which, as relatively small businesses within the company, are currently in the process of being reviewed and repositioned. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, has been granted 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for treating severe obstructive sleep apnea (“OSA”) in adults using the exclusive Vivos removable Complete Airway Repositioning and/or Expansion (“CARE”) oral appliances. According to the announcement, CARE appliances include Vivos’s flagship DNA oral appliance as well as its mRNA oral appliance and mmRNA oral appliance. This clearance makes Vivos the first company to have approved and brought to market a clear alternative treatment to CPAP or surgical neurostimulation implants for patients with severe OSA. The company noted that the clearance from the FDA came only 11 months after the agency granted Vivos 510(k) clearance for the DNA oral appliance to treat mild-to-moderate OSA.

“This achievement is a pivotal milestone for Vivos and elevates our proven treatment options right into the mainstream of sleep medicine,” said Vivos chair and CEO Kirk Huntsman in the press release. “It is even more important for the millions of severe OSA patients who are desperate for an effective alternative treatment. Before this, severe OSA patients’ only realistic treatment options were CPAP, neurostimulation implants or other invasive surgeries. Today, they have what we believe is a far more desirable option that is very affordable and doesn’t require surgery or a lifetime of nightly use and intervention. Vivos trained providers can now treat patients with OSA and conditions associated with OSA comprehensively using our suite of FDA-cleared devices, without regard to the severity of their OSA condition and across a range of price point options. We believe this unprecedented decision by the FDA will generate broader acceptance throughout the medical community for Vivos treatment options, leading to the potential for higher patient referrals and case starts as well as collaboration with medical professionals. We also believe it will enhance our value proposition to third-party distribution partners such as durable medical equipment (‘DME’) companies. This approval could also clear the way for greater reimbursement levels from medical insurance payors and Medicare. We believe that all these factors should favorably impact our ability to grow our revenues in 2024 and beyond.”

To view the full press release, visit https://ibn.fm/J8bc1

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in the treatment of approximately 40,000 patients worldwide by more than 1,850 trained dentists. The Vivos Method includes treatment regimens that employ the proprietary Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

iClick (NASDAQ: ICLK) is a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions. The company today announced that it will hold its 2023 annual general meeting on Dec. 29, 2023, at 9:00 a.m. ( Hong Kong time) or on Dec. 28, 2023, at 8:00 p.m. (New York time) in Hong Kong, People’s Republic of China. Only shareholders of record at the close of business on Nov. 29, 2023, (New York Time) are entitled to receive notice of and to attend the company’s annual general meeting or any adjournment or postponement thereof. The notice of iClick’s annual general meeting and its 2022 annual report containing the complete audited financial statements and the report of auditors for the year ended Dec. 31, 2022, are available on the investor relations section of the company’s website.

To view the full press release, visit https://ibn.fm/ojMyY

About iClick Interactive Asia Group Limited

Founded in 2009, iClick is a leading enterprise and marketing cloud platform in China. iClick’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has filed the required reports for its Q3 2023, the period ended Sept. 30, 2023. The reports include its Condensed Interim Consolidated Unaudited Financial Statements, Management Discussion and Analysis and associated certifications. Highlights of the report included revenues totaling $20.1 million for the third quarter and $69.1 million for the first nine months of fiscal 2023; gross profit, before fair value adjustments, resulting in $7.9 million for the third quarter; and year-to-date gross profit coming in at $21.1 million. The report also noted general and administrative expenses for the quarter totaled $6.4 million with operating expenses reported at $8.4 million for the quarter. The report stated that Adjusted EBITDA for Q3 2023 was $1.6 million, an increase of $1.3 million from Q2 2023. Corporate highlights included the successful launch of the company’s Platinum-branded vape products in the Ontario market; the execution of a licensing agreement with an Ohio distributor, enabling the company’s entry into the rapidly growing Ohio cannabis market; the closing of an asset purchase by a wholly owned subsidiary of the company; and the announcement by the company and Aleafia Health Inc. that the previously announced Amended Stalking Horse Agreement had satisfied substantially all of the conditions for closing, with the anticipated closing expected no later than Dec. 15, 2023.

“Our company remains committed to expanding our premium Platinum-branded product line, with successful launches in Canada during Q3 and recent entry into the Ohio market in Q4,” said Red White & Bloom president Colby De Zen in the press release. “Our previously outlined investments in optimizing manufacturing facilities through value-added enhancements, driven by automation and procurement strategies, are now yielding labor and product-cost efficiencies, as evidenced in our expanded reported gross profit for the quarter ended. Additionally, we are gearing up for the introduction of several new product offerings in Florida, anticipating full extraction capabilities. Upon approval, we foresee incremental revenue and gross margin growth through the launch of distillate-based products. Throughout the first nine months of 2023, our efforts have focused on cost reduction, eliminating low-margin products and noncore revenue streams, while placing a heightened emphasis on higher-margin products. With the impending completion of the Aleafia acquisition, RWB is poised to emerge as a leading international branded cannabis company as we head into 2024.”

To view the full press release, visit https://ibn.fm/AeCfn

About Red White & Bloom Brands Inc.

Red White & Bloom is a multistate cannabis operator and house of premium brands in the U.S. legal cannabis sector. RWB is predominantly focusing its investments on the major U.S. markets, including Arizona, California, Florida, Massachusetts, Missouri, Michigan and Ohio, as well as targeted Canadian markets. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and post-traumatic stress disorder, has announced clarifications regarding its Special Access Support and Supply Program (“SASSP”). The SASSP is MYCOF’s proprietary program designed to provide products and services to physicians, clinics and hospitals in Canada that are looking to treat patients through psychedelic-assisted psychotherapy. According to the announcement, access to the program is available exclusively through its partner, Applied Pharmaceutical Innovation (“API”), pursuant to a Health Canada license granted to Dr. Raimar Loebenberg. Based on that agreement, API is able to provide patients with access to certain controlled substances, including psilocybin and MDMA. Mydecine itself does not have the ability to grant patients access to controlled substances through the program. The company noted that any previous references to the program in press release, social media or website content was not intended to promote the availability of unauthorized drugs to Canadians or suggest that those drugs have any authorized therapeutic uses in Canada.

To view the full press release, visit https://ibn.fm/j0p0G

About Mydecine Innovations Group Inc.

Mydecine Innovations Group is a publicly traded, prerevenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was founded to increase physicians’ access to serotonin-modulating medicine. Recent research has demonstrated the therapeutic potential of psychedelic substances such as psilocybin and MDMA for treating intractable conditions such as pain, anxiety, depression, addiction and PTSD, along with neurodegenerative disorders. Mydecine believes these compounds can be safer, more effective, and more accessible for patients and medical professionals through modern drug chemistry paired with artificial intelligence (“AI”). Mydecine is developing innovative medications for target indications with high mortality rates that have lacked innovation for decades and are controlled by dominant corporations. Mydecine developed several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. Mydecine is also developing MYCO-006, or short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. Mydecine utilizes cutting-edge AI and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them affordable and accessible to the general public upon Health Canada and FDA approval. The Mydecine team is enthusiastic about its mission and is dedicated to creating a positive difference in the lives of others. For more information about the company, please visit mydecine.com.

NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

EverGen (TSX.V: EVGN) (OTCQX: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has been awarded a new five-year agreement with the City of Abbotsford. The agreement calls for EverGen to process all of the city’s organic waste through to its curbside collection program at the company’s Pacific Coast Renewables (“PCR”) facility. EverGen projects the total of organic waste to be 16,000 tonnes annually. According to the announcement, the agreement notes that the waste will be processed at a 40% increased average price and will include the completion of composting infrastructure upgrades. Upgrades include a new aerated flooring system, temperature monitoring equipment, the construction of stormwater diversion infrastructure, and advanced automation and improvements to compost blowers. In addition, the company noted that it has signed a strategic compost marketing agreement with a third-party vendor to manage the distribution of all soil produced at Pacific Coast Renewables. The contract streamlines logistical operations at the facility and is projected to result in significant cost reductions as well as a 90% reduction in disposal costs associated with byproducts of the composting process. “We are excited to continue our partnership with the city of Abbotsford in managing their organic waste,” said EverGen CEO and president Mischa Zajtmann in the press release. “With our recently completed composting upgrades at the Pacific Coast Renewables facility, we have established a state-of-the-art central processing hub for the region. With the support of the city, this contract will supply the valuable feedstock for a future RNG processing facility at PCR.”

To view the full press release, visit https://ibn.fm/PUt3q

About EverGen Infrastructure Corp.

EverGen, Canada’s renewable natural gas infrastructure platform, is combating climate change and helping communities contribute to a sustainable future. Headquartered on the west coast of Canada, EverGen is an established independent renewable energy producer that acquires, develops, builds, owns and operates a portfolio of renewable natural gas, waste-to-energy and related infrastructure projects. EverGen is focused on Canada, with continued growth expected across other regions in North America and beyond. For more information about EverGen and its products, visit www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced another expansion sale through Knightscope Authorized Partner (“KAP”) Transportation Solutions & Lighting, Inc., – Safety and Security Division – National Safety Systems (“NSS/TS&L”). As a result, NSS/TS&L will supply, install and support 14 solar powered K1 Blue Light Emergency Towers throughout a university campus in eastern Tennessee.

The announcement reads, “Knightscope’s state-of-the-art emergency blue light towers and call boxes allow anyone to call for help when and where it is needed, regardless of power or location. These devices allow for greater coverage, improved access and better cost control in maintaining campus safety, which is why they have become such a familiar sight at institutions of higher education across the United States.”

To view the full press release, visit https://ibn.fm/uOoGG

About Knightscope, Inc.

Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information, visit the company’s website at www.knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

RYVYL (NASDAQ: RVYL), a leading innovator of payment-transaction solutions leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, has entered into a second exchange agreement with an existing noteholder. According to the announcement, the agreement will forbear the note repayment requirement until April 5, 2025, and exchange the outstanding principal in a new authorized series of preferred stock. The agreement outlines a series of exchanges as well as a cash payment of $3 million, which the company has agreed to make for an additional $3,600,000 reduction in principal of the note. At the anticipated closing date of the agreement, which is on or around Nov. 29, 2023, RYVYL’s debt is expected to be reduced to $19,700,000. “We believe that the noteholder’s agreement to convert a significant portion of its debt holdings to equity in the company evidences its continued support and its belief in RYVYL’s core mission,” said RYVYL chair Ben Errez in the press release. “Once completed, we will have a stronger balance sheet, significantly increasing net shareholder equity and reducing outstanding debt by more than $60 million. It is our hope that by bringing net shareholder equity back into compliance with NASDAQ’s listing standards, we will be able to maintain the listing of our common stock on NASDAQ as we look to continue to grow our disruptive payment transaction technology to diverse global markets.”

To view the full press release, visit https://ibn.fm/Td6Ug

About RYVYL Inc.

RYVYL’s cutting-edge blockchain, ledger-based platform offers a seamless and secure payment experience tailored for the diverse and ever-evolving global market. By harnessing the power of blockchain technology, the company ensures unparalleled security, transparency and immutability in all transactions. RYVYL’s commitment to simplicity guarantees a user-friendly interface accessible to everyone, while robust compliance measures instill trust and confidence across borders and regulatory landscapes. For more information about the company, please visit www.RYVYL.com.

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Nate’s Food Co. (OTC: NHMD), a forward-thinking company dedicated to providing high-quality food products and services, has obtained official registration from the General Administration of Customs of the People’s Republic of China (“GACC”). According to the company, the registration is a “pivotal moment” as it clears the path for the execution of contracts for a diverse range of commodities in the Chinese market. The company noted that receiving the registration underscores its unwavering dedication to adherence to compliance, unwavering commitment to quality and strategic pursuit of global market expansion. This regulatory milestone gives the company essential approval needed to import a diverse array of food products, providing key opportunities in the rapidly expanding Chinese market. The company is now focused on leveraging this milestone and delivering exceptional commodities to the Chinese market. The company anticipates that the GACC registration will serve as a catalyst for further growth, solidifying its standing as a key player in the global food industry. “We are thrilled to have secured GACC registration,” said Nate’s Food Co. CEO Nate Steck in the press release. “This achievement unlocks new possibilities for our company, allowing us to fulfill contracts for commodities and better serve our partners and customers in the Chinese market.”

To view the full press release, visit https://ibn.fm/6EPdl

About Nate’s Food Co.

Nate’s Food is a forward-thinking company dedicated to providing high-quality food products and services. With a focus on innovation and growth, Nate’s Food continually seeks opportunities to enhance shareholder value while exploring new markets and optimizing operations.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

MetAlert (OTC: MLRT), a pioneer in GPS wearable technology and global provider in the field of human and asset tracking and recovery systems, has announced financial results for the third quarter ended Sept. 30, 2023, and provided a corporate summary. Among the highlights, the company reported a 27% revenue increase and 343% cash-on-hand increase over the 2022 comparable period. “During the third quarter 2023, we took transformative steps to broaden our product line and add new markets in order to increase our revenues and subscriptions. We successfully acquired Level 2 Security LLC, which we merged into our new 100% wholly owned subsidiary Level 2 Security Products Inc. Management believes this was a formidable step in solidifying the financial and operational position of the company and encapsulates our vision to amplify recurring revenue streams while scaling the company’s life-saving technology and IP portfolio,” said MetAlert CEO Patrick Bertagna. “We also saw some positive trends such as a 27% increase in revenues compared to Q3 of 2022 and a 76% increase in revenues over the previous quarter in 2023. We also had our best ending cash position ($106,000) and asset value ($744,000) since 2021. Included in the acquisition came bank balances, intellectual property, approximately 3,700 units of ready to ship product inventory, digital collateral, an online and Amazon store, two smartphone apps, and an ongoing research and development roadmap for possible future new product releases. The strategic synergy from the acquisition enables us to expand our target market beyond those of humans with cognitive disorders and opens the doors to entirely new and much larger markets. The Level 2 proprietary technology can safeguard an extensive range of mobile assets, and by integrating this with MetAlert’s backend tracking portal and infrastructure, the company envisions fiscal improvements in the near term.”

To view the full press release, visit https://ibn.fm/Dm5f7

About MetAlert Inc.

MetAlert and its subsidiaries occupy a commanding position in the design, development, manufacturing, distribution, sales, and licensing of GPS wearable technology, asset recovery services, wandering assistive technology, and health data collection and monitoring. With over two decades of industry expertise and a robust portfolio of patents, MetAlert is the go-to solution provider for consumers and patients grappling with mobility, cognitive and spatial awareness challenges. This demographic represents approximately 2.9% of the global population. The company delivers comprehensive global solutions encompassing logistics, hardware, software, and connectivity. Notable achievements include the groundbreaking GPS SmartSole(R), a fusion of Dr. Scholl’s comfort with LoJack’s tracking prowess. It stands as the world’s inaugural invisible wearable tracking device, designed for individuals susceptible to wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based model thrives on technology innovation fortified by intellectual property safeguards. The company boasts international distribution channels serving customers across 40 countries, alongside its role as a U.S. Military Government contractor. In addition to public health entities, MetAlert caters to municipalities, emergency and law enforcement agencies, private educational institutions, assisted living facilities, NGOs, senior care residences, consumers, and small enterprises. Recognizing its excess capacity within its distribution center and backend processes also presents an opportunity to expand revenue streams and diversify its operations.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, and its board of directors has initiated a process to evaluate potential strategic alternatives. The goal of the process is to identify ways to unlock and maximize shareholder value. According to the announcement, company officials are working with financial and legal advisors as they consider a full range of strategic, operational and financial options. The announcement noted that there is no assurance that the strategic review process will result in the approval or completion of any specific transaction or outcome, and the company has not established a timeline for completion of the review process. Company officials don’t anticipate making any additional comments regarding the process unless or until board members approve a definitive course of action or determine that additional comments are appropriate.

To view the full press release, visit https://ibn.fm/DPWVj

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research and, where appropriate, combination therapy. The company’s current primary focus is a novel program to treat several inflammatory disorders using anti-TNF, or tumor necrosis factor. For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has entered into a new contract outlining plans to provide is cardiometabolic solution to an employer. The contract will begin in January 2024. The new contract is the latest is a growing number of similar agreements, indicating that demand for Dario’s integrated solutions continues to grow as employers facing the surge in GLP-1 medication usage search for ways to change health behaviors. According to the announcement, the employer is a national financial and business services company that chose Dario as a solution to help improve the cardiometabolic health of its employees with an integrated solution for diabetes, prediabetes, weight management and hypertension; the proprietary DRIO program also offers tailored support for employees taking GLP-1 medications. “Dario is seeing increased interest in our proven ability to help people achieve better cardiometabolic health through sustained behavior change, a requirement for people using medications such as GLP-1s,” said Dario president Rick Anderson in the press release. “We are excited to support our new client’s business goals with effective and easy-to-use solutions which we believe employees will love.”

To view the full press release, visit https://ibn.fm/SeTKs

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Siyata Mobile (NASDAQ: SYTA), a global developer and vendor of push-to-talk over cellular (“PoC”) handsets and accessories, today announced its receipt of a purchase order from its Canadian resell partner and private LTE/5G engineering firm, Solutions Ambra Inc. (“Ambra”) for the company’s SD7 push-to-talk (“PTT”) handsets, VK7 vehicle kits and related accessories. “This order establishes Siyata in a new vertical market and demonstrates the compatibility and durability of products. Our hardware will operate on a private LTE/5G network that Ambra created and deployed specifically to service mining operations in a remote area,” said Marc Seelenfreund, CEO of Siyata. “Telecom coverage by mainstream providers is generally broad, but there are remote areas where coverage is not ubiquitous. Accordingly, there is a current and growing trend of mining companies turning to private cellular-based networks to support operations with reliable and secure communications. Importantly, the private network provides the backbone and catalyst for transitioning away from land mobile radio communication. We know that Ambra Solutions are experts in mission-critical communications having already deployed many private LTE/5G networks in underground and open-pit mines, so we are happy to work with them. We believe there is a compelling opportunity for our solutions to be used on private networks such as with mining operations, where reliable communication is critical to safety and efficient operations.”

To view the full press release, visit https://ibn.fm/WFz4f

About Siyata Mobile Inc.

Siyata Mobile is a B2B global developer and vendor of next-generation push-to-talk (“PTT”) over cellular handsets and accessories. Its portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice to increase situational awareness and save lives. Police, fire and ambulance organizations as well as schools, utilities, security companies, hospitals, waste management companies, resorts and many other organizations use Siyata PTT handsets and accessories today. In support of its PTT handsets and accessories, Siyata also offers enterprise-grade in-vehicle solutions and cellular booster systems enabling its customers to communicate effectively when they are in their vehicles, and even in areas where the cellular signal is weak. Siyata sells its portfolio through leading North American cellular carriers and through international cellular carriers and distributors. Siyata’s common shares and its previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. Visit SiyataMobile.com and UnidenCellular.com to learn more.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Progressive Care (OTCQB: RXMD), a personalized healthcare services and technology provider, and its wholly owned subsidiary PharmcoRx Pharmacy, are expanding their in-pharmacy offerings. The expansion comes as the result of an agreement with the Mark Cuban Cost Plus Drug Company (“MCCPDC”), which offers a Cost Plus Drugs program that gives participating patients the ability to purchase both generic and branded medicines at cost plus a low fixed markup. According to the announcement, the program includes more than 1,000 drugs, offered at actual acquisition cost plus a 15% markup. MCCPDC recently unveiled its Team Cuban Card, which is a free prescription benefit program designed to provide consumers around the country with low-cost medications. Based on the agreement, PharmcoRx locations will be a participating pharmacy in the program and will be listed in the Team Cuban Card provider directory. “Through our inclusion in the Team Cuban Card provider network, we are quickly able to expand our PharmcoRx pharmacy offerings by providing consumers with increased access to medications at a significantly reduced cost,” said Progressive Care chief operating officer Pamela Roberts in the press release. “By partnering with organizations such as the Mark Cuban Cost Plus Drug Company and our ongoing initiatives to expand our pharmacy service offerings and reach, we are continuing our mission to make positive contributions to the health of our customers.”

To view the full press release, visit https://ibn.fm/gDRW7

About Progressive Care

Progressive Care, through its subsidiaries, is a Florida health services organization and provider of third-party administration (“TPA”), data management, COVID-19-related diagnostics and vaccinations, 340B contracted pharmacy services, prescription pharmaceuticals, compounded medications, provider of telepharmacy services, the sale of anti-retroviral medications, medication therapy management (“MTM”), the supply of prescription medications to long-term care facilities, and health practice risk management. Progressive Care became a subsidiary of NextPlat Corp. (NASDAQ: NXPL) on July 1, 2023. For more information about the company, visit www.ProgressiveCareUS.com

NOTE TO INVESTORS: The latest news and updates relating to RXMD are available in the company’s newsroom at https://ibn.fm/RXMD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

PowerTap Hydrogen Capital (NEO: MOVE) (OTC: MOTNF), a leading provider of onsite hydrogen production technology, has released an update on the status of the management cease trade order (“MCTO”) issued in September 2023. The MCTO was received from the British Columbia Securities Commission after PowerTap reported that it would be delayed in filing its financial statements and accompanying management’s discussion and analysis for the fiscal year ended June 30, 2022. According to the announcement, the general investing public may continue to trade in PowerTap listed common shares during the MCTO while the company’s CEO and CFO are not permitted to do so. The company notes that it is working with its auditor, Zeifmans LLP, to file the required reports. “Other than as disclosed in this news release, there are no material changes to the information contained in the default announcement,” the company said in the press release. “The company confirms that it intends to satisfy the provisions of NP 12- 203 and will continue to issue biweekly default status reports for so long as it remains in default of the annual filings requirement.”

To view the full press release, visit https://ibn.fm/qwRfs

About PowerTap Hydrogen Capital Corp.

PowerTap Hydrogen, through its wholly owned subsidiary PowerTap Hydrogen Fueling Corp., is focused on installing hydrogen production and dispensing fueling infrastructure in the United States. PowerTap’s patented solution has been developed over 20 years. PowerTap is now commercializing its third-generation blue hydrogen product that will focus on the refueling needs of the automotive and long-haul trucking markets that lack hydrogen fueling infrastructure. For more information about the company, please visit www.PowerTapCapital.com.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

iClick Interactive (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, has entered into a definitive agreement and plan of merger. The agreement is with TSH Investment Holding Limited and TSH Merger Sub Limited. The agreement will result in the company becoming a wholly owned subsidiary of TSH Investment Holding Limited. According to the announcement, funds for the merger will come from a combination of a cash contribution from Rise Chain Investment Limited, debt financing provided by New Age SP II and equity rollover by the rollover shareholders. The announcement noted that the board had unanimously approved the merger agreement and the merger, and unanimously resolved to recommend that iClick shareholders vote to authorize and approve the merger agreement and merger as well. It is anticipated that the merger will close in Q1 2024; the transaction is subject to customary closing conditions including an affirmative vote of shareholders representing at least two-thirds of the voting power of the outstanding shares present and voting in person or by proxy at a meeting of company shareholders.

To view the full press release, visit https://ibn.fm/OqaJp

About iClick Interactive Asia Group Limited

iClick is a leading enterprise and marketing cloud platform in China. The company’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information about the company, please visit www.iClick.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

EverGen (TSX.V: EVGN) (OTCQX: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, is reporting its third-quarter financial results and corporate milestones. Highlights of the report include mechanical completion at EverGen’s Fraser Valley Biogas RNG expansion project, with the first RNG on track for December 2023; an agreement with Irving Oil for up to 60,000 GJ of RNG annually produced from the GrowTEC RNG facility; the signing of a 10-year organic waste-processing agreement with the city of Regina; and a $7 million senior term loan agreement with BDC. In addition, the company reported a 17% increase in revenues for the quarter, which came in at C$2.3 million, up from C$2 million in Q3 2022; net loss of C$1.1 million for quarter, down 40% from C$1.8 million the same quarter in 2022; and Adjusted EBITDA of C$0.4 million for Q3 2023, a slight decrease from Q3 2022. “This quarter marks the commencement of a significant ramp up in revenue across our platform,” said EverGen Infrastructure CEO Mischa Zajtmann in the press release. “With mechanical completion at Fraser Valley Biogas and the addition of another material organics processing facility in Regina, the foundation has been set for future revenue growth as we continue to execute on core project delivery.”

To view the full press release, visit https://ibn.fm/Jbfzb

About EverGen Infrastructure Corp.

EverGen, Canada’s renewable natural gas infrastructure platform, is combating climate change and helping communities contribute to a sustainable future. Headquartered on the west coast of Canada, EverGen is an established independent renewable energy producer that acquires, develops, builds, owns and operates a portfolio of renewable natural gas, waste-to-energy and related infrastructure projects. EverGen is focused on Canada, with continued growth expected across other regions in North America and beyond. For more information about EverGen and its products, visit www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, has filed a bankable feasibility study (“BFS”) for its wholly owned Crawford Nickel Sulphide Project. Titled “Crawford Nickel Sulphide Project NI 43-101 Technical Report and Feasibility Study,” the study was prepared independently by Ausenco Engineering Canada Inc. The world’s second largest nickel reserve, the Crawford project is expected to become one of Canada’s largest carbon-storage facilities and be a net negative contributor of CO2. Highlights of the project include robust economics and a large initial mineral reserve anchored by a significantly larger mineral resource. The large-scale project, which is located in Ontario, is projected to be a low-cost, long-life operation, producing 83 million pounds of nickel on average over a 41-year life with projected revenue exceeding $1 billion over the project life with significant improvement in recoveries from PEA along with a minimal carbon footprint.

To view the full release, visit https://ibn.fm/7zSIh

About Canada Nickel Company Inc.

Canada Nickel is advancing the next generation of nickel-cobalt sulphide projects to deliver nickel required to feed the high-growth electric vehicle and stainless-steel markets. Canada Nickel Company has applied in multiple jurisdictions to trademark the terms NetZero Nickel(TM), NetZero Cobalt(TM) and NetZero Iron(TM), and is pursuing the development of processes to allow the production of net-zero carbon nickel, cobalt and iron products. Canada Nickel provides investors with leverage to nickel in low political-risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information about the company, visit www.CanadaNickel.com.

NOTE TO INVESTORS: The latest news and updates relating to CNIKF are available in the company’s newsroom at https://ibn.fm/CNIKF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

IBN (InvestorBrandNetwork), a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60+ brands, today announced its re-engagement as the official media partner for The Microcap Conference. Organized by DealFlow Events, the conference is slated to take place from Jan. 30 to Feb. 1, 2024, at the renowned Caesars Atlantic City Hotel & Casino in Atlantic City, New Jersey. The eagerly awaited event will serve as a crucial platform for investment, education and collaboration and will feature specialized programming geared towards the microcap space. As the media sponsor, IBN will harness its comprehensive corporate communications solutions to enhance the conference’s visibility through an impressive array of strategic tools and influential digital channels.

“At DealFlow, we are pleased to once again collaborate with IBN for our January event,” said Steven Dresner, CEO of DealFlow Events. “As the market leader in corporate communications, IBN has always greatly improved our outreach and ensured seamless media coverage at our conferences. We are tremendously excited about our event in January and appreciate IBN’s continued support.”

To view the full press release, visit https://ibn.fm/wpLzJ

About IBN

IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (“DBP”), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN